Definition, prediction, prevention and management of patients with severe ischemic stroke and large infarction
- PMID: 38030579
- PMCID: PMC10752492
- DOI: 10.1097/CM9.0000000000002885
Definition, prediction, prevention and management of patients with severe ischemic stroke and large infarction
Abstract
Severe ischemic stroke carries a high rate of disability and death. The severity of stroke is often assessed by the degree of neurological deficits or the extent of brain infarct, defined as severe stroke and large infarction, respectively. Critically severe stroke is a life-threatening condition that requires neurocritical care or neurosurgical intervention, which includes stroke with malignant brain edema, a leading cause of death during the acute phase, and stroke with severe complications of other vital systems. Early prediction of high-risk patients with critically severe stroke would inform early prevention and treatment to interrupt the malignant course to fatal status. Selected patients with severe stroke could benefit from intravenous thrombolysis and endovascular treatment in improving functional outcome. There is insufficient evidence to inform dual antiplatelet therapy and the timing of anticoagulation initiation after severe stroke. Decompressive hemicraniectomy (DHC) <48 h improves survival in patients aged <60 years with large hemispheric infarction. Studies are ongoing to provide evidence to inform more precise prediction of malignant brain edema, optimal indications for acute reperfusion therapies and neurosurgery, and the individualized management of complications and secondary prevention. We present an evidence-based review for severe ischemic stroke, with the aims of proposing operational definitions, emphasizing the importance of early prediction and prevention of the evolution to critically severe status, summarizing specialized treatment for severe stroke, and proposing directions for future research.
Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.
Conflict of interest statement
None.
Figures
References
-
- Wu S Wu B Liu M Chen Z Wang W Anderson CS, et al. . Stroke in China: Advances and challenges in epidemiology, prevention, and management. Lancet Neurol 2019;18: 394–405. doi: 10.1016/s1474-4422(18)30500-3. - PubMed
-
- Hacke W Kaste M Bluhmki E Brozman M Dávalos A Guidetti D, et al. . Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359: 1317–1329. doi: 10.1056/NEJMoa0804656. - PubMed
-
- Jovin TG Chamorro A Cobo E de Miquel MA Molina CA Rovira A, et al. . Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015;372: 2296–2306. doi: 10.1056/NEJMoa1503780. - PubMed
-
- Hofmeijer J Kappelle LJ Algra A Amelink GJ van Gijn J van der Worp HB, et al. . Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy after Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): A multicentre, open, randomised trial. Lancet Neurol 2009;8: 326–333. doi: 10.1016/s1474-4422(09)70047-x. - PubMed
-
- Torbey MT Bösel J Rhoney DH Rincon F Staykov D Amar AP, et al. . Evidence-based guidelines for the management of large hemispheric infarction: A statement for health care professionals from the Neurocritical Care Society and the German Society for neuro-intensive care and emergency medicine. Neurocrit Care 2015;22: 146–164. doi: 10.1007/s12028-014-0085-6. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
